fda compounding glp-1 enforcement news today 2025 Congress Introduces SAFE Drugs Act of 2025, Expanding Oversight of Compounded Drugs and Telehealth Providers Compounded GLP-1s: What to Do

These effects on tumor progression and survival are accompanied by beneficial changes in immune cell infiltrates within the microenvironment

Chemicals that are produced by living organisms are called toxins

Once you understand who your consumer is and what drives their decisions, the next step is figuring out how to reach them and how your tech fits into the story they want to tell about themselves

It's enough to have a serious conversation with your rheumatologist, especially if you have RA plus excess weight, insulin resistance, or elevated cardiovascular risk

Note also that the compounding market tightened in 2025 to 2026 after the FDA removed semaglutide and tirzepatide from shortage, so pharmacy access to compounded products now generally requires a documented clinical rationale